206 related articles for article (PubMed ID: 16490630)
21. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
[TBL] [Abstract][Full Text] [Related]
22. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
[TBL] [Abstract][Full Text] [Related]
23. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
[TBL] [Abstract][Full Text] [Related]
24. Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.
O'Brien MA; Mason NA
Clin Pharm; 1992 Mar; 11(3):246-54. PubMed ID: 1611814
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
26. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
Thomae U; Koblinger S
Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
[TBL] [Abstract][Full Text] [Related]
27. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.
Yeung SM; Walker SE; Tailor SA; Awdishu L; Tobe S; Yassa T
Perit Dial Int; 2004; 24(5):447-53. PubMed ID: 15490984
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients.
Elwell RJ; Manley HJ; Frye RF; Bailie GR
Int J Artif Organs; 2005 Aug; 28(8):808-16. PubMed ID: 16211531
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal ceftriaxone].
Ragnaud JM; Bezian MC; Dupon M; Marceau C; Wone C
Pathol Biol (Paris); 1988 May; 36(5):552-6. PubMed ID: 3043356
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
[TBL] [Abstract][Full Text] [Related]
36. Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
Stea S; Bachelor T; Cooper M; de Souza P; Koenig K; Bolton WK
J Am Soc Nephrol; 1996 Nov; 7(11):2399-402. PubMed ID: 8959631
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
Albarellos GA; Ambros LA; Landoni MF
Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
[TBL] [Abstract][Full Text] [Related]
38. Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis.
Cardone KE; Grabe DW; Zasowski EJ; Lodise TP
Antimicrob Agents Chemother; 2014; 58(1):19-26. PubMed ID: 24126585
[TBL] [Abstract][Full Text] [Related]
39. A drug-induced turbid peritoneal dialysate in five patients treated with continuous ambulatory peritoneal dialysis.
Yoshimoto K; Saima S; Echizen H; Nakamura Y; Ishizaki T
Clin Nephrol; 1993 Aug; 40(2):114-7. PubMed ID: 8222367
[TBL] [Abstract][Full Text] [Related]
40. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
